Patents by Inventor Laurent Pierre Rivory

Laurent Pierre Rivory has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8097715
    Abstract: Interfering RNA molecules are now designed and produced with specificity for multiple binding sequences present in distinct genetic contexts in one or more pre-selected target RNA molecules and are used to modulate expression of the target sequences. The multitargeting interfering RNA molecules have two strands that target multiple target sites on one or more pre-selected RNA molecules. Such a multitargeting interfering RNA approach provides a powerful tool for gene regulation.
    Type: Grant
    Filed: May 21, 2008
    Date of Patent: January 17, 2012
    Assignee: Johnson & Johnson Research PTY Limited
    Inventors: Laurent Pierre Rivory, Michael Poidinger, Donald John Birkett, Gregory Martin Arndt, Toby Passioura
  • Publication number: 20100286238
    Abstract: The present invention concerns methods and reagents useful in decreasing the level of or severity of respiratory infection or disease due to paramyxoviruses, such as RSV or HPIV, or coronavirus infection. Particularly, the invention relates to modulating gene expression using a multitargeting interfering RNA molecules that target multiple target sites on one or more pre-selected RNA molecules.
    Type: Application
    Filed: May 14, 2008
    Publication date: November 11, 2010
    Inventors: Laurent Pierre Rivory, Michael Poidinger, Donald John Birkett, Gregory Martin Arndt, Toby Passioura
  • Publication number: 20090312399
    Abstract: The present invention relates to guanosine-rich oligonucleotides having the capacity to induce cell death, having characteristics of programmed cell death, in non-quiescent cells of higher eukaryotic organisms. The invention also relates to therapeutic methods involving the administration of these nucleic acid molecules to subjects suffering from, or being predisposed to, disorders involving abnormal cell proliferation and migration. The invention also concerns pharmaceutical compositions comprising the guanosine-rich nucleic acid molecules, in association with suitable carriers.
    Type: Application
    Filed: June 28, 2006
    Publication date: December 17, 2009
    Applicant: JOHNSON & JOHNSON RESEARCH PTY, LTD
    Inventors: Laurent Pierre Rivory, Donald John Birkett
  • Publication number: 20090239816
    Abstract: Interfering RNA molecules are now designed and produced with specificity for multiple binding sequences present in distinct genetic contexts in one or more pre-selected target RNA molecules and are used to modulate expression of the target sequences. Such a multitargeting interfering RNA approach provides a powerful tool for gene regulation.
    Type: Application
    Filed: May 21, 2008
    Publication date: September 24, 2009
    Applicant: Johnson & Johnson Research PTY. Limited
    Inventors: Laurent Pierre Rivory, Michael Poidinger, Donald John Birkett, Gregory Martin Arndt, Toby Passioura
  • Publication number: 20090192103
    Abstract: Interfering RNA molecules are now designed and produced with specificity for multiple binding sequences present in distinct genetic contexts in one or more pre-selected target RNA molecules and are used to modulate expression of the target sequences. The multitargeting interfering RNA molecules have two strands that target multiple target sites on one or more pre-selected RNA molecules. Such a multitargeting interfering RNA approach provides a powerful tool for gene regulation.
    Type: Application
    Filed: May 21, 2008
    Publication date: July 30, 2009
    Applicant: Johnson & Johnson Research PTY. Limited
    Inventors: Laurent Pierre RIVORY, Michael Poidinger, Donald John Birkett, Gregory Martin Arndt, Toby Passioura